Taubman Institute funds early-detection COVID study that uses wearable devices

Early in the wake of the pandemic as new epidemiological data were emerging, a major concern shared by healthcare workers (HCWs) was the potential to transmit virus without any warning signs. A critical unaddressed issue is whether early detection, especially of infection before obvious symptoms, can prevent “pre-symptomatic transmission” and stop further spread.   Sung…

Institute supports first U-M based COVID study

A team of University of Michigan physician-researchers have launched a clinical trial of a drug they believe may address the deadly blood clots that form in some patients with COVID-19. The trial is the first COVID-related investigation to be initiated by Michigan Medicine scientists. The trial is based on the results of a blood inflammation…

TIIP investigator will study immune response in COVID patients

A Michigan Medicine physician-investigator and recipient of a Taubman Institute Innovation Projects (TIIP) grant will use samples from COVID-19 patients to study how the virus affects a patient’s immune profile. Daniel Goldstein, MD,  last year began a TIIP study that will scrutinize the immune system of organ transplant patients in an effort to refine the…

Taubman Emerging Scholar Sheds Light on Possible Suicide Risk of Covid-19 Front Line Caretakers

Srijan Sen, MD, PhD, Associate Professor, Psychiatry, Associate Vice President for Health Sciences, and Frances and Kenneth Eisenberg Professor of Depression and Neurosciences, is one of five mental health care providers and advocates who discuss elevated suicide risk in the most recent issue of BridgeMI.com. In the article, Dr. Sen says, “There is this issue…

Taubman Institute Scholar Inducted into National Academy of Sciences

The Taubman Institute salutes Scholar Arul Chinnaiyan, MD, PhD, one of four U-M physician-researchers inducted into the National Academy of Sciences class of 2020 on April 27. Dr. Chinnaiyan is the S.P. Hicks Endowed Professor of Pathology, Professor of Urology, Director of the Michigan Center for Translational Pathology in the Medical School, Howard Hughes Medical…

Taubman Scholar named Director, Medical Scientist Training Program

Marschall S. Runge, MD, PhD, Dean, University of Michigan Medical School, Executive Vice President for Medical Affairs, U-M and CEO, Michigan Medicine announced that Kathleen L. Collins, MD, PhD, has been appointed director of the Medical Scientist Training Program (MSTP) in the Medical School. She is a professor of microbiology and immunology and internal medicine…

Taubman Emerging Scholar publishes new stem cell research

By Ian Demsky Senior Writer, U-M Rogel Cancer Center    How do a couple of universally expressed proteins in stem cells and developing embryos influence an individual cell’s ultimate fate — whether it ultimately becomes, for example, a retinal cell, a heart muscle cell, or a stomach lining cell? That’s the question that Rajesh C.…

Institute funds new precision health project

The Taubman Institute will co-sponsor a new DNA sequencing project that aims to expand knowledge of the human genome and its role in disease. “Short Tandem Repeats in Precision Health and Human Disease” will be jointly supported by the institute and the Michigan Medicine Precision Health research initiative. The project is one of seven funded…

2019 Symposium

The 2019 Taubman Prize Symposium featured a keynote by prize recipient Professor Sir Stephen O’Rahilly, MD, of the University of Cambridge. Dr. O’Rahilly, an endocrinologist and researcher, spoke on “The Causes and Consequences of Human Obesity.” He accepted the award from Gayle Taubman Kalisman, PhD.

#GivingBlueday gifts will aid exciting medical research

Their genius. Your generosity. The Taubman Institute extends its heartfelt appreciation to all of the donors who generously contributed to our Emerging Scholars on December 3, Giving Blueday. The laboratories of five researchers will receive your gifts in early January, helping them to further investigations into depression, autoimmune disorders, cancer, dementia and more. Thank you…